CervoMed Inc. (CRVO)
NASDAQ: CRVO · Real-Time Price · USD
8.65
-0.04 (-0.46%)
Dec 8, 2025, 12:37 PM EST - Market open
CervoMed Stock Forecast
Stock Price Forecast
The 6 analysts that cover CervoMed stock have a consensus rating of "Strong Buy" and an average price target of $21.5, which forecasts a 148.55% increase in the stock price over the next year. The lowest target is $15 and the highest is $31.
Price Target: $21.5 (+148.55%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CervoMed stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +258.38% | Dec 5, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +258.38% | Dec 2, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +258.38% | Nov 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $11 → $25 | Hold → Strong Buy | Upgrades | $11 → $25 | +189.02% | Nov 5, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +258.38% | Nov 4, 2025 |
Financial Forecast
Revenue This Year
5.26M
from 9.74M
Decreased by -45.96%
Revenue Next Year
1.10M
from 5.26M
Decreased by -79.06%
EPS This Year
-2.51
from -2.02
EPS Next Year
-2.01
from -2.51
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 7.3M | 5.0M | ||||
| Avg | 5.3M | 1.1M | ||||
| Low | 4.2M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -24.5% | -4.2% | ||||
| Avg | -46.0% | -79.1% | ||||
| Low | -56.7% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.45 | -0.57 | ||||
| Avg | -2.51 | -2.01 | ||||
| Low | -2.90 | -2.83 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.